MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Improving compliance to Parkinsonism’s pharmacotherapy amongst patients attending a Movement Disorders Clinic (MDC)

M. Alsahab, S. Pradhan, A. Chatterjee (Reading, United Kingdom)

Meeting: 2018 International Congress

Abstract Number: 888

Keywords: Parkinsonism, Pharmacotherapy

Session Information

Date: Sunday, October 7, 2018

Session Title: Other

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To improve patients’ compliance with Parkinsonism’s pharmacotherapy to achieve more accurate clinical assessment in an outpatient setting.

Background: Patients with Parkinsonism are encouraged to take their medications on time whether at home or in hospital. A number of campaigns are run internationally to ensure that patients always receive the drug on time when admitted to hospital; however data for outpatient clinic is lacking.

Methods: A survey was conducted amongst the Parkinsonism patients attending a multidisciplinary MDC between January to March 2017. Data was collected on a structured proforma, recording time of arrival to clinic, whether medications were brought in, and the time the medications were due. Data was analysed and changes were implemented. This included a modification of the appointment letter reminding patients to bring their medication, a new patient information leaflet; a “Get it on Time” poster was drafted for the clinic area to raise awareness. Further data was collected between November 2017 and January 2018.

Results: 38 patients were included in the first survey, the average age was 82.5 and 55% were male. 45 patients were included in the second survey, the average age was 80.6 and 64.4% were females. 82.2 % (37/45) brought the new appointment letter.

Conclusions: Our quality improvement project has led to a significant proportion of Parkinsonism patients (39% to 75%) bringing their medications to the multidisciplinary MDC. This has helped to make an accurate assessment of their motor (bradykinesia, dyskinesia and gait) and non-motor symptoms leading to appropriate advice on pharmacotherapy and other strategies including gait, posture and cueing.

To cite this abstract in AMA style:

M. Alsahab, S. Pradhan, A. Chatterjee. Improving compliance to Parkinsonism’s pharmacotherapy amongst patients attending a Movement Disorders Clinic (MDC) [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/improving-compliance-to-parkinsonisms-pharmacotherapy-amongst-patients-attending-a-movement-disorders-clinic-mdc/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/improving-compliance-to-parkinsonisms-pharmacotherapy-amongst-patients-attending-a-movement-disorders-clinic-mdc/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley